[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353869-105":59,"doc-detail-353869-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","comparative-modeling-of-recent-and-projected-trends-in-the-incidence-and-mortality-of-uterine-cancer-original-research","Comparative Modeling of Recent and Projected Trends in the Incidence and Mortality of Uterine Cancer - Original Research","","Three distinct natural history simulation models of uterine cancer were developed, calibrated, and validated to support cancer control and prevention by projecting future population burden. The models include two state-transition microsimulation approaches and a multistage clonal expansion framework, all calibrated to SEER 18 incidence data while accounting for time-varying hysterectomy and obesity trends. Following calibration, incidence and mortality were projected to 2050, showing comparable model performance and substantial continued increases in disease burden.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/comparative-modeling-of-recent-and-projected-trends-in-the-incidence-and-mortality-of-uterine-cancer-original-research/353869/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/comparative-modeling-of-recent-and-projected-trends-in-the-incidence-and-mortality-of-uterine-cancer-original-research/353869.png","ImageObject",300,407,{"name":92,"@type":93},"Mia  ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the study objective for uterine cancer modeling?","Question",{"text":112,"@type":113},"To aid cancer control and prevention by developing, calibrating, and validating three distinct natural history simulation models of uterine cancer and using them to project future incidence and mortality.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which modeling approaches were used in the study?",{"text":117,"@type":113},"The study used two state-transition microsimulation models and one multistage clonal expansion model, all simulating uterine cancer incidence and mortality.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the models project for incidence and mortality through 2050?",{"text":121,"@type":113},"All three models projected substantial and continued increases in uterine cancer incidence and incidence-based mortality through 2050, with higher projected rates among non-Hispanic Black women than among non-Hispanic White women.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},353869,1790570655,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687207024478,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Original Research  \nComparative Modeling of Recent and Projected Trends in the Incidence and Mortality of Uterine Cancer  \nKevin J. Rouse, William D. Hazelton, PhD, Axel Frotscher, Ling Chen, MD, Matthew T. Prest, Jennifer S. Ferris, PhD, Xiao Xu, PhD, Alexander Melamed, MD, Chin Hur, MD,  \nBrandy M. Heckman-Stoddard, PhD, MPH, Goli Samimi, PhD, MPH, Nina A. Bickell, MD, Tracy M. Layne, PhD, MPH, Stephanie V. Blank, MD, Elena B. Elkin, PhD, Evan R. Myers, MD, Laura J. Havrilesky, MD, Chung Yin Kong, PhD, and Jason D. Wright, MD  \nOBJECTIVE: To aid in cancer control and prevention activities by developing, calibrating, and validating three distinct natural history simulation models of uterine cancer, a growing public health concern.  \nMETHODS: To perform comparative analyses, we developed two state-transition microsimulation models and a multistage clonal expansion model of uterine cancer. The models simulate uterine cancer incidence and mortality. All three models were calibrated to common data on the incidence of uterine cancer from the Surveillance, Epidemiology, and End Results (SEER) 18 database. Each model accounts for changing trends in hysterectomy and obesity over time and simulates incidence and mortality for endometrioid and nonendometrioid tumors and uterine sarcoma. After calibration, we projected the incidence and mortality of uterine cancer to 2050.  \nRESULTS: The three uterine cancer models were well calibrated to population data and produced comparable results for projecting the burden of disease through 2050. Among non-Hispanic White women aged 40 years or older, the models project that by 2050 the incidence of uterine cancer will rise to 76.1–81.8 per 100,000 womanyears, up from 2018 SEER incidence of 60.0 per 100,000 woman-years. Among non-Hispanic Black women, new cases will rise to 90.3–107.2 per 100,000 woman-years, up from 2018 SEER incidence of 61.3 per 100,000 woman-years. Within these populations, incidence-based mortality will increase to 11.3– 12.3 deaths per 100,000 woman-years for non-Hispanic White women and to 28.2–35.7 deaths per 100,000 woman-years for non-Hispanic Black women.  \nCONCLUSION: Three distinct mathematical simulation models of uterine cancer have been calibrated to  \nFrom the Department of Obstetrics and Gynecology and the Department of Medicine, Columbia University College of Physicians and Surgeons, the Herbert Irving Comprehensive Cancer Center, New York–Presbyterian Hospital, the Division of General Internal Medicine and the Department of Obstetrics, Gynecology, and Reproductive Science, and Population Health, Icahn School of Medicine atMount Sinai, and the Department of Health Policy and Management, Joseph L. Mailman School of Public Health, Columbia University, New York, New York; the Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, Massachusetts; the National Cancer Institute, Bethesda, Maryland; the Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina; and the Herbold Computational Biology Program, Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington.  \nThis study was supported by National Cancer Institute 1U01 CA265739 to the Cancer Intervention and Surveillance Modeling Network Uterine Cancer Group (contact principal investigator Dr. Wright) .  \nJason D. Wright, Editor-in-Chief of Obstetrics & Gynecology, was not involved in the review or decision to publish this article.  \nEach author has confirmed compliance with the journal’s requirements for authorship. Drs. Rouse, Hazelton, Frotscher, and Chen are co-first authors.  \nDrs. Havrilesky, Kong, and Wright are co-senior authors.  \nCorresponding author: Jason D. Wright, MD, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Columbia University College of Physicians and Surgeons, New York, NY; [jason.wright@tuftsmedicine.org](jason.wright@tuftsmedicine.org).  \nFinancial Disclosure  \nDr. Wright","cbCaijfI8Ft8y7iM","https://ap.wps.com/l/cbCaijfI8Ft8y7iM","pdf",2033660,11,"English","# Objective\n# Methods\n# Results\n# Conclusion\n# Disclosures and Publication Notes","[{\"question\":\"What was the study objective for uterine cancer modeling?\",\"answer\":\"To aid cancer control and prevention by developing, calibrating, and validating three distinct natural history simulation models of uterine cancer and using them to project future incidence and mortality.\"},{\"question\":\"Which modeling approaches were used in the study?\",\"answer\":\"The study used two state-transition microsimulation models and one multistage clonal expansion model, all simulating uterine cancer incidence and mortality.\"},{\"question\":\"What did the models project for incidence and mortality through 2050?\",\"answer\":\"All three models projected substantial and continued increases in uterine cancer incidence and incidence-based mortality through 2050, with higher projected rates among non-Hispanic Black women than among non-Hispanic White women.\"}]","Comparative Modeling of Recent and Projected Trends in the Incidence and Mortality of Uterine Cancer - Original Research | PDF",1790107664,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0f16b4f8eede64b2b3988b4bc651960d.webp",983,1363,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/740962474c8475f84ae49a9c65c3d918.webp",982,1362,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2c9719965d813d0f99fc2ae725c7540c.webp",981,1361,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9b4acd079011aa4ea3578e9cfab48e5a.webp",980,1359]